Internet-delivered Cognitive-Behavioral Therapy (iCBT) for Adults with Prolonged Grief Disorder (PGD): A Study Protocol for a Randomized Feasibility Trial
| Autor: | Sonia Mor, Rocío Herrero, Daniel Campos, Soledad Quero, Alba López-Montoyo, Cintia Tur, Diana Castilla |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Adult
medicine.medical_specialty Mindfulness protocols & guidelines media_common.quotation_subject medicine.medical_treatment Psychological intervention Prolonged grief disorder 03 medical and health sciences 0302 clinical medicine Quality of life (healthcare) medicine therapeutics Humans 030212 general & internal medicine Psychiatry Randomized Controlled Trials as Topic media_common Internet Cognitive Behavioral Therapy business.industry Conducta (Psicologia) General Medicine Mental health 030227 psychiatry Cognitive behavioral therapy Treatment Outcome Mental Health Spain Quality of Life Feasibility Studies Anxiety Medicine Grief Mort medicine.symptom business mental health |
| Zdroj: | BMJ Open, Vol 11, Iss 7 (2021) Zaguán. Repositorio Digital de la Universidad de Zaragoza instname Repositori Universitat Jaume I Universitat Jaume I Tur Domenech, Cintia Campos, Daniel Herrero, Rocío Mor Rodríguez, Sonia López Montoyo, Alba Castilla López, Diana Virginia Quero Castellano, Soledad 2021 Internet-delivered Cognitive-Behavioral Therapy (iCBT) for Adults with Prolonged Grief Disorder (PGD): A Study Protocol for a Randomized Feasibility Trial Bmj Open 11 e046477 1 11 BMJ Open |
| ISSN: | 2044-6055 |
| Popis: | IntroductionGrief is an emotional reaction to the loss of a loved one with a natural recovery. Approximately 10% of people who lose a loved one develop prolonged grief disorder (PGD). Internet-based and computer-based interventions (ie, internet-delivered cognitive–behavioural therapy, iCBT) are a cost-effective alternative that makes it possible to reach more people with PGD. The main aim of this study is to assess the feasibility of a new iCBT—called GROw—for PGD. As a secondary objective, the potential effectiveness of GROw will be explored.Methods and analysisThis study is a two-arm feasibility randomised trial. A total of 48 adults with PGD who meet the eligibility criteria will be randomised to the experimental group (iCBT: GROw) or the active control group (face-to-face CBT treatment). The treatment is organised sequentially in eight modules in the iCBT format and 8–10 sessions in the face-to-face format, and both formats have the same therapeutic components. There will be five assessment points with qualitative and quantitative evaluations: screening, baseline, after the intervention, 3-month follow-up and 12-month follow-up. Consistent with the objectives, the measures are related to the feasibility outcomes for the main aim of the study (participant adherence, expectations and satisfaction with the treatment, preferences, alliance and utility) and psychological and mental health outcomes for secondary analyses (symptoms of grief, symptoms of depression, symptoms of anxiety, affectivity, quality of life, work and social adaptation, post-traumatic growth, purpose in life, mindfulness and compassion).Ethics and disseminationThe Ethics Committee of the Universitat Jaume I (Castellón, Spain) granted approval for the study (CD/002/2019). Dissemination will include publications and presentations at national and international conferences.Trial registration numberNCT04462146. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|